Abeona Therapeutics Inc. (ABEO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 279.06M |
| Enterprise Value | 225.59M |
| P/E Ratio | 4.51 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 22.74 |
| Price/Book Ratio | 2.27 |
| Enterprise/Revenue | 20.11 |
| Enterprise/EBITDA | 3.98 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 4.55 |
| Operating Margin | -6.38 |
| Return On Assets | 0.33 |
| Return On Equity | 0.41 |
| Revenue | 5.82M |
| Revenue/Share | 0.26 |
| Gross Profit | 4.29M |
| EBITDA | 78.59M |
| Net Income | 71.18M |
| Diluted EPS | 1.01 |
| Total Cash | 168.27M |
| Total Cash/Share | 2.97 |
| Total Debt | 23.17M |
| Total Debt/Equity | 0.16 |
| Current Ratio | 5.89 |
| Book Value Per Share | 2.56 |
| 52-Week Change | -0.17 |
| 52-Week High | 7.54 |
| 52-Week Low | 4 |
| Moving Average 50 Days | 5.53 |
| Moving Average 200 Days | 5.24 |
| Average Volume | 1.1M |
| Shares Outstanding | 57M |
| % Held by Institutions | 0 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | July 05, 2022 |